A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Last in line to presented is the company Readily Diagnostics. Readily Diagnostics' technology is based on padlock probes and rolling circle amplification (RCA), combined with a proprietary solution to enhance speed. It integrates a molecular method with microfluidics, allowing for use in various settings or with standard laboratory equipment for high throughput. This technology offers the robustness and specificity of RT-PCR without requiring specialized instruments. "We are incredibly excited and honored to have been selected for the BIO-X Accelerate program! We see this as validation that our diagnostic tests will make a significant difference in healthcare. With the support of BIO-X Accelerate, we can now take further steps to develop our clinical test, advance our regulatory journey towards CE-IVD certification, and offer it to healthcare providers more quickly." — Liza Löf (Mokvist), PhD, CEO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Readily Diagnostics and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
STUNS Life science
Samhällsorganisationer och sociala organisationer
STUNS Life science promotes the growth of a strong and sustainable life science sector.
Om oss
STUNS Life science supports growth and international competitiveness in life science. STUNS Life science is an independent and not-for-profit actor and a significant driving force for many developments within the region. The organization ensures a holistic perspective and offers a neutral meeting place. Continued collaboration – regional, national, and international – is vital for the sector to continue to develop and grow. We bring together relevant expertise and resources from the universities, companies, healthcare, and society to support a wide variety of collaborations, projects, and events.
- Webbplats
-
http://www.stuns.se
Extern länk för STUNS Life science
- Bransch
- Samhällsorganisationer och sociala organisationer
- Företagsstorlek
- 2–10 anställda
- Huvudkontor
- Uppsala
- Typ
- Ideell organisation
- Grundat
- 1983
- Specialistområden
- Innovation support, Networking, Health och Life science
Adresser
-
Primär
Uppsala Science Park
Uppsala, 75183, SE
Anställda på STUNS Life science
Uppdateringar
-
A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Next in line is the company Phenaros Pharmaceuticals. Phenaros Pharmaceuticals use AI and automation to accelerate drug discovery. They employ state-of-the-art AI to guide decisions, along with robotics and automation for intelligent experimentation. As a data-centric company, Phenaros Pharmaceuticals systematically engineers the data used to build their AI system, enabling them to perform the right experiments at the right time, while reducing costs and time in drug discovery cycles. "BIO-X Accelerate offers substantial value for us by providing funding and strategic support to validate and scale our drug discovery platform. This initiative allows us to solidify our technology by partnering with leading pharmaceutical companies and enhances our ability to contribute to bringing effective drugs to market faster." — Jordi Carreras Puigvert, CSO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Phenaros Pharmaceuticals and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
-
-
A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Next in line is the company Strike Pharma AB. Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC) technology to take precision medicine to a new level, enabling development of truly individualized immunotherapeutic treatments based on the genetic profile of each patient’s tumor. "BIO-X Accelerate not only accelerates our product validation contributing to the establishment of our unique technology now also positioned for antibody-based delivery of oligonucleotide-based therapeutics, but also establishes a foundation for future industrial partnerships. Being selected is a recognition of our project’s value to the industry, society, and patients.” Sara Mangsbo, CSO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Strike Pharma and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
-
-
A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Next in line to be presented is the company ArgusEye. ArgusEye provides sensor solutions for real-time detection of biological systems and processes. The company’s patented sensor technology is the result of extensive academic research at Linköping University and is based on nanoplasmonic sensing combined with fiber optics. By adding specific receptors, the company can offer flexible and sensitive sensing systems for a variety of targets. "BIO-X Accelerate will help us accelerate towards our goal of developing biosensors that can fundamentally reshape the biopharmaceutical industry. This support allows us to prioritize product development of a new product which will further allow us to offer solutions that cover the entire bioprocessing chain." Nathalie Elsässer, COO ArgusEye. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet ArgusEye and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
-
-
A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. First to be presented is the company Rarity Bioscience . Rarity Bioscience was founded in 2021 as a spin-out from Uppsala University to further develop and commercialize the superRCA® assay technology. Rarity superRCA® is an ultrasensitive multiplex assay for detecting rare nucleic acid sequences in liquid biopsy or tissue samples. "BIO-X Accelerate gives us the opportunity to dedicatedly drive this project all the way to regulatory approval. It also validates our vision, ambition, and ability to impact and improve cancer care." - Linus Bosaeus, CEO Rarity Bioscience AB. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Rarity Bioscience and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
-
-
We thrilled to officially announce the pioneering companies selected for the BIO-X Accelerate program! Congratulations to: 🌟 ArgusEye – Revolutionizing bioprocessing with advanced biosensors. 🌟 Rarity Bioscience – Pioneering precision cancer diagnostics. 🌟 Readily Diagnostics – Developing rapid and impactful diagnostic tests. 🌟 Phenaros Pharmaceuticals – Innovative drug development. 🌟 Strike Pharma AB – Taking precision medicine to a new level. “We are very pleased to welcome these five innovative companies to the BIO-X Accelerate program. Previous rounds have shown that our support has contributed to companies attracting significant investment and taking important steps forward in their development. With the new participants, we look forward to continuing to drive innovation in life science and health, and contribute to a sustainable and digital transformation." – Dajana I., Project Manager for the BIO-X Accelerate program at STUNS. BIO-X Accelerate was initiated in 2020 with the goal of facilitating the transition of small and medium-sized enterprises within the region’s life science sector from the early stages to a rapid phase of innovation and growth. The project aimed to enhance the competitiveness of these companies by generating innovative products that have high demand in the global healthcare market. The BIO-X Accelerate program will be in progress during 2024-2026 with these companies and the new theme “IMPACT”. Read the full press release👇 https://lnkd.in/dFN99UQV This project is funded by The European Regional Development Fund (ERDF) via Tillväxtverket. Thanks to our strategic and supporting partners: UIC - Uppsala Innovation Centre, Connect Sverige Region Uppsala, LEAD (Business Incubator), Inkubera, Create Business Incubator, Linköpings universitet, Uppsala universitet and Örebro universitet Holding. #Uppsala #Lifescience #Innovation
-
Med ökande krav och snabba förändringar inom life science, blir kvalitetssäkring alltmer kritiskt. Hur mycket tid och resurser lägger din organisation på att säkerställa kvalitet? Ett robust kvalitetsledningssystem är avgörande för att bygga förtroende hos investerare och partners. Hur prioriterar ni kvalitet i er verksamhet? Kommentera och dela med dig av tankar och erfarenheter! #mpyascitech #STUNS #Phosworks #biotechdatenight #Kvalitetsledning #BioteknikStartups Connect Sverige Region Uppsala
-
#Uppsala Missa inte nästa LIFE PUB som sker den 24 september hos Olink Proteomics som numera är en del av Thermo Fisher Scientific. Vi kommer lära oss mer om dem och deras resa och möjligheter samt få se deras fina lokaler nere på stan. Begränsat med platser - så anmäl ert intresse redan idag på den externa länken! Vi ses där Som vanligt i samarbete med Connect Sverige Region Uppsala och Corem Property Group Uppsala Business Park Tack för bra samarbete: Henrik Gistvall Mille Söderberg Arvid Callin Nerdal Philip Svanfeldt Anna Mankert Sara Brännström Alida Säflund Anna Marsell Jon Heimer Dajana I. Björn Arvidsson Erik Allard Malin Wiederholm Fanny Blom Anisha Khan Alexander Nordström Asha Khan
Innehållet är inte tillgängligt här
Få tillgång till det här innehållet och mycket mer i LinkedIns app
-
Looking for investment opportunities in the life science and healthtech sector? On September 12th, we are hosting an investment meeting together with Connect Sverige Region Uppsala, in connection with the kickoff of the BIO-X Accelerate program. Don’t miss the chance to meet the selected BIO-X winners: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. We´ll also feature bonus pitches from BIO-X applicants: Cellda AB, Extrem Pharma, MyCural Therapeutics, Oxlantic Medical AB and Stardots. Ping to our strategic and supporting partners: UIC - Uppsala Innovation Centre, Create Business Incubator, Inkubera, Connect Sverige Region Uppsala, LEAD (Business Incubator), Uppsala universitet, Linköpings universitet and Örebro universitet. Share this opportunity with investors in your networks! 📆 September 12th 🕒 15:00-19:00 📍 Kungsgatan 36A (Bjerking’s office) Register for the event now: https://lnkd.in/dC33tgcM Read more about the event and companies here: https://lnkd.in/diurc_gd
Register for the event now!
stuns-life-science.web.app
-
Tune in to the third episode of The Silent Facilitators! In this episode we meet Carolina Pettersson , who gives us her insights on cross-industry recruitment, how a major consultancy operates, different career paths in consulting and much more. The podcast is available on Podcaster and Spotify (”Speed of Life”) and the link can be found in the comments. The Silent Facilitators is a podcast series by Stuns Life Science where we put the spotlight on service providers in the Life Science industry. Oskar Wiggins Elliot Westerlind #TheSilentFacilitators #LifeScience #Uppsala #Consulting
-